相似文献
1
Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.
Cancer Immunol Immunother. 1989;29(4):242-6. doi: 10.1007/BF00199211.
2
Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells.
Br J Haematol. 2001 Mar;112(3):740-8. doi: 10.1046/j.1365-2141.2001.02596.x.
3
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Br J Haematol. 2007 May;137(4):297-306. doi: 10.1111/j.1365-2141.2007.06547.x. Epub 2007 Apr 4.
4
In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia.
Bone Marrow Transplant. 1998 Dec;22(12):1185-90. doi: 10.1038/sj.bmt.1701511.
5
Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Blood. 1996 Mar 15;87(6):2476-85.
6
Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.
Br J Haematol. 1996 Mar;92(3):587-94.
7
Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
Br J Haematol. 2003 Jan;120(1):63-73. doi: 10.1046/j.1365-2141.2003.03979.x.
8
Chronic myeloid leukemia as an immunological target.
Am J Hematol. 1997 Jan;54(1):61-7. doi: 10.1002/(sici)1096-8652(199701)54:1<61::aid-ajh9>3.0.co;2-2.
9
b3a2 BCR-ABL fusion peptides as targets for cytotoxic T cells in chronic myeloid leukaemia.
Br J Haematol. 2000 Jun;109(3):616-21. doi: 10.1046/j.1365-2141.2000.02090.x.
引用本文的文献
1
The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes.
Cancer Immunol Immunother. 2003 Feb;52(2):89-96. doi: 10.1007/s00262-002-0362-7. Epub 2003 Jan 21.
2
Biological significance of autologous tumor-killing activity and its induction therapy.
Cancer Immunol Immunother. 1993 Jul;37(2):75-83. doi: 10.1007/BF01517038.
3
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.
Cancer Immunol Immunother. 1990;32(3):167-72. doi: 10.1007/BF01771452.
4
Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.
Cancer Immunol Immunother. 1991;33(1):54-60. doi: 10.1007/BF01742529.
本文引用的文献
1
Allogeneically primed T lymphocyte clones in the analysis of lymphocyte stimulatory determinants.
Hum Immunol. 1983 Dec;8(4):239-47. doi: 10.1016/0198-8859(83)90050-2.
2
Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines.
J Immunol. 1982 Nov;129(5):2271-6.
3
Cloning of human lymphocytes reactive with autologous leukemia cells.
Cancer Res. 1980 Sep;40(9):3218-21.
4
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.
Science. 1986 Sep 19;233(4770):1318-21. doi: 10.1126/science.3489291.
5
MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
Cancer Immunol Immunother. 1988;27(3):205-12. doi: 10.1007/BF00205441.
6
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
J Exp Med. 1988 Oct 1;168(4):1419-41. doi: 10.1084/jem.168.4.1419.
7
Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.
Cancer Immunol Immunother. 1988;27(2):183-9. doi: 10.1007/BF00200025.
8
In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.
Cancer Immunol Immunother. 1988;27(2):177-82. doi: 10.1007/BF00200024.
9
Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cells.
Eur J Haematol. 1988 Apr;40(4):362-7. doi: 10.1111/j.1600-0609.1988.tb00192.x.
10
Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytes.
Cancer Immunol Immunother. 1988;27(3):255-60. doi: 10.1007/BF00205448.
Zotero 插件